Found: 19
Select item for more details and to access through your institution.
Pilot evaluation of scrambler therapy for pain induced by bone and visceral metastases and refractory to standard therapies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Chemotherapy-induced anemia in breast cancer patients treated with pegfilgrastim-supported dose-dense regimens.
- Published in:
- Clinical & Experimental Medicine, 2010, v. 10, n. 2, p. 135, doi. 10.1007/s10238-009-0072-y
- By:
- Publication type:
- Article
Phase II Open-Label Study to Assess Efficacy and Safety of Lenalidomide in Combination with Cetuximab in <i>KRAS</i>-Mutant Metastatic Colorectal Cancer.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0062264
- By:
- Publication type:
- Article
Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1197, doi. 10.3390/cancers14051197
- By:
- Publication type:
- Article
The Evolutionary Landscape of Treatment for BRAF V600E Mutant Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 1, p. 137, doi. 10.3390/cancers13010137
- By:
- Publication type:
- Article
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Colorectal Cancer, 2017, v. 16, n. 3, p. e153, doi. 10.1016/j.clcc.2017.01.004
- By:
- Publication type:
- Article
Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Esophageal Cancer with Early Onset in a Patient with Cri du Chat Syndrome.
- Published in:
- Diseases, 2024, v. 12, n. 1, p. 9, doi. 10.3390/diseases12010009
- By:
- Publication type:
- Article
High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00622
- By:
- Publication type:
- Article
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 224, p. 1, doi. 10.1126/scitranslmed.3007947
- By:
- Publication type:
- Article
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.
- Published in:
- Nature, 2012, v. 486, n. 7404, p. 532, doi. 10.1038/nature11156
- By:
- Publication type:
- Article
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literature.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Correction to: Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum to: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.
- Published in:
- 2012
- By:
- Publication type:
- Correction Notice
Integrated molecular dissection of the epidermal growth factor receptor (EGFR) [corrected] oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The Quest for Improving Treatment of Cancer of Unknown Primary (CUP) Through Molecularly-Driven Treatments: A Systematic Review.
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00533
- By:
- Publication type:
- Article
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer.
- Published in:
- BMC Cancer, 2011, v. 11, n. 1, p. 247, doi. 10.1186/1471-2407-11-247
- By:
- Publication type:
- Article